“fda” Archives

in
Entry Author Date Location
West Coast Biotech Roundup: Grail, Juno, Amgen, Imprimis & More 02/12/16 San Diego
East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More 02/11/16 New York
Biogen’s Scangos on Pricing, Deals, Hemophilia, Alzheimer’s & More 02/09/16 Boston
BioCryst Stock Tanks After Rare Disease Drug’s Phase 2 Failure 02/08/16 Raleigh Durham
San Antonio’s TRTF Reboots Seed VC Fund 02/08/16 Texas
Syngenta, NC Biotech, PSEG Solar, & More NC Innovation News 02/08/16 Raleigh Durham
BioDirection Scoops Up $4M for 90-Second Diagnostic of Concussions 02/03/16 Boston
FDA Puts Heat Biologics Bladder Cancer Trial on Partial Hold 02/03/16 Raleigh Durham
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
Houston HealthIT Company Decisio Raises $2.1M in Funds, Adds Lawson to Board 02/02/16 Texas
Texas Roundup: Datical, CPRIT, Pivot3, SonarMed, TMCx, & CareAline 02/01/16 Texas
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
West Coast Biotech Roundup: Gilead, Adicet, Otonomy, Fate & More 01/29/16 San Diego
FDA Gives Nod to SonarMed Device For Monitoring Newborns 01/27/16 Texas
Safety Issues Spur Foundation-Backed Akashi to Suspend Duchenne Trial 01/26/16 Boston
Heat Biologics Seeks More Cash for Bladder Cancer Immunotherapy Push 01/22/16 Raleigh Durham
West Coast Biotech Roundup: StemCells, Five Prime, Qualcomm & More 01/22/16 San Francisco
Armed With $30M, Akili Plans Bigger Trial of Therapeutic Video Game 01/22/16 Boston
East Coast Biotech Roundup: Alkermes, Zafgen, Snowmaggedon & More 01/22/16 Boston
Some Good News, Finally, for Zafgen’s Obesity Drug 01/20/16 Boston
FDA Rejects BioMarin’s Duchenne Drug, Sarepta Up Next 01/14/16 San Francisco
Medical Test Validity Will Be Debated In 2016: 5 Storylines To Watch 01/14/16 Wisconsin
$100M Richer, Cempra Still Needs FDA OK To Market Pneumonia Drug 01/07/16 Raleigh Durham
Artificial Intelligence Growing Slowly in Healthcare, And That’s OK 01/06/16 Wisconsin
Oncology’s Future: Liquid Biopsies and the Heterogeneity of Cancer 01/05/16 San Diego
Chimerix Stock Plunges After Anti-Infection Drug Fails Phase 3 Trial 12/28/15 Raleigh Durham
Innovation vs. Healthcare Spending: Biotech’s Biggest Looming Challenge 12/28/15 National
West Coast Biotech Roundup: Otonomy, Oncothyreon, Gilead, & More 12/14/15 San Diego
Pozen, Tribute Pharma Nix Ireland Move in Favor of Canada HQ 12/08/15 Raleigh Durham
Austin’s Stellarray Looks to Develop the Next Wave of X-Ray 12/03/15 Texas
Page 1 of 49 next page »